IBI: AJ387; Sanja Mijatović***, naučni savetnik, Univerzitet u Beogradu, Institut za biološka istraživanja 'Siniša Stanković'; Polje: prirodno-matematičke i medicinske nauke; Period: 2020-2024;
eNauka profil: rp06448; ORCID: 0000-0001-9509-9098;
WOS indikatori: NR = 138; TC = 4606; HIndex = 34;
eNauka WOS indikatori: NR = 166; TC = 4613; HIndex = 34 ;
Lista A broj bodova: 293.7432 (552) 5.8%; Lista B broj bodova: 1763.8133 (552) 6.0%; Lista C broj bodova: 0.000 (0) nan%; Lista A broj bodova kolaboracije: 0.00303 (373) 81.2%; Lista B broj bodova kolaboracije: 291.534 (373) 1.1%;
Statistika svih rezultata
| Statistika | Ukupno | 2013-2024 | 2015-2024 | 2018-2024 | 2020-2024 |
|---|---|---|---|---|---|
| Broj rezultata | 138 | 94 | 79 | 62 | 45 |
| Broj citata | 4606 | 3327 | |||
| Broj M bodova | 402.00 | 402 | 402.00 | 402 | |
| Normirani broj citata | 2397.83 | 1763.81 | |||
| Normirani broj M bodova rezultata kategorije M21a++M21a+M21+M22+M23+M24 | 293.74 | 293.74 | 293.74 | 293.74 | |
| Normirani broj M bodova rezultata kategorije M11+M12+M13+M14+M41 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Normirani broj M bodova rezultata kategorije M11+M12+M13+M14+M41+M42 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Normirani broj M bodova rezultata kategorije M51 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Normirani broj M bodova rezultata kategorije M43+M44 | 0.00 | 0.00 | 0.00 | 0.00 |
Statistika rezultata nastalih u medunarodnim kolaboracijama
| Statistika | Ukupno | 2013-2024 | 2015-2024 | 2018-2024 | 2020-2024 |
|---|---|---|---|---|---|
| Broj rezultata sa 20 i više autora | 7 | 2 | 1 | 0 | 0 |
| Broj citata rezultata sa 20 i više autora | 1824 | 1308 | |||
| Broj M bodova rezultata M21a++M21a+M21+M22+M23 sa 20 i više autora | 0.00 | 0 | 0.00 | 0 | |
| Normirani broj citata rezultata sa 20 i više autora | 407.28 | 291.53 | |||
| Normirani broj M bodova rezultata M21a++M21a+M21+M22+M23 sa 20 i više autora | 0.00 | 0.00 |
Rezultati
| RB | IBI | Godina | Kat | Tip | Vrsta | Referenca | TC | TCP | BA | NBB | NTC | Naslov | Autori | 1. | AJ387 | 1996 | E | TRANSPLANTATION PROCEEDINGS Vol. 28 (6): # 3257 - 3257 (1), (DOI: ) DEC 1996WOS | 1 | 0 | 4 | 0 | 0.0000 | Enhancement of Th2-type activity downregulated diabetes induction | StosicGrujicic S, Mijatovic S, Ejdus L, Lukic M | 2. | AJ387 | 1996 | E | TRANSPLANTATION PROCEEDINGS Vol. 28 (6): # 3258 - 3258 (1), (DOI: ) DEC 1996WOS | 1 | 0 | 5 | 0 | 0.0000 | Etretinate (Ro 10-9359) prevents autoimmune syndrome associated with chronic graft-versus-host disease in rats | StosicGrujicic S, Ejdus L, Mijatovic S, Jovanovic S, Ostojic N | 3. | AJ387 | 2004 | E | CELLULAR AND MOLECULAR LIFE SCIENCES Vol. 61 (14): # 1805 - 1815 (11), (DOI: 10.1007/s00018-004-4089-9) JUL 2004WOS | 41 | 15 | 8 | 0 | 12.5000 | Aloe-emodin prevents cytokine-induced tumor cell death: the inhibition of auto-toxic nitric oxide release as a potential mechanism | Mijatovic S, Maksimovic-Ivanic D, Radovic J, Popadic D, Momcilovic M, Harhaji L, Miljkovic D, Trajkovic V | 4. | AJ387 | 2005 | E | CELLULAR AND MOLECULAR LIFE SCIENCES Vol. 62 (5): # 589 - 598 (10), (DOI: 10.1007/s00018-005-4425-8) MAR 2005WOS | 91 | 38 | 9 | 0 | 27.1429 | Anti-glioma action of aloe emodin: the role of ERK inhibition | Mijatovic S, Maksimovic-Ivanic D, Radovic J, Miljkovic D, Harhaji L, Vuckovic O, Stosic-Grujicic S, Stojkovic M, Trajkovic V | 5. | AJ387 | 2005 | E | CELLULAR AND MOLECULAR LIFE SCIENCES Vol. 62 (11): # 1275 - 1282 (8), (DOI: 10.1007/s00018-005-5041-3) JUN 2005WOS | 66 | 18 | 7 | 0 | 18.0000 | Aloe emodin decreases the ERK-dependent anticancer activity of cisplatin | Mijatovic S, Maksimovic-Ivanic D, Radovic J, Miljkovic D, Kaludjerovic G, Sabo T, Trajkovic V | 6. | AJ387 | 2006 | E | JOURNAL OF NEUROSCIENCE RESEARCH Vol. 84 (2): # 379 - 388 (10), (DOI: 10.1002/jnr.20883) AUG 1 2006WOS | 51 | 18 | 10 | 0 | 11.2500 | Strain difference in susceptibility to experimental autoimmune encephalomyelitis between albino oxford and dark agouti rats correlates with disparity in production of IL-17, but not nitric oxide | Miljkovic D, Stosic-Grujicic S, Markovic M, Momcilovic M, Ramic Z, Maksimovic-Ivanic D, Mijatovic S, Popadic D, Cvetkovic I, Mostarica-Stojkovic M | 7. | AJ387 | 2007 | E | EUROPEAN JOURNAL OF PHARMACOLOGY Vol. 568 (1-3): # 248 - 259 (12), (DOI: 10.1016/j.ejphar.2007.04.029) JUL 30 2007WOS | 35 | 16 | 7 | 0 | 16.0000 | Aloe emodin inhibits the cytotoxic action of tumor necrosis factor | Harhaji L, Mijatovic S, Maksimovic-Ivanic D, Popadic D, Isakovic A, Todorovic-Markovic B, Trajkovic V | 8. | AJ387 | 2008 | E | FOOD AND CHEMICAL TOXICOLOGY Vol. 46 (5): # 1825 - 1833 (9), (DOI: 10.1016/j.fct.2008.01.027) MAY 2008WOS | 70 | 40 | 11 | 0 | 22.2222 | Anti-tumor effect of Coriolus versicolor methanol extract against mouse B16 melanoma cells:: In vitro and in vivo study | Harhaji L, Mijatovic S, Maksimov-Ivanic D, Stojanovic I, Momcilovic M, Maksimovic V, Tufegdzic S, Marjanovic Z, Mostarica-Stojkovic M, Vucinic Z, Stosic-Grujicic S | 9. | AJ387 | 2008 | E | NITRIC OXIDE-BIOLOGY AND CHEMISTRY Vol. 19 (2): # 177 - 183 (7), (DOI: 10.1016/j.niox.2008.04.004) SEP 2008WOS | 21 | 6 | 16 | 0 | 2.1429 | Novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide (GIT-27NO) induces p53 mediated apoptosis in human A375 melanoma cells | Mijatovic S, Maksimovic-Ivanic D, Mojic M, Malaponte G, Libra M, Cardile V, Miljkovic D, Harhaji L, Dabideen D, Cheng K, Bevelacqua Y, Donia M, Garotta G, Ai-Abed Y, Stosic-Grujicic S, Nicoletti F | 10. | AJ387 | 2008 | E | MOLECULAR CANCER THERAPEUTICS Vol. 7 (3): # 510 - 520 (11), (DOI: 10.1158/1535-7163.MCT-07-2037) MAR 2008WOS | 69 | 36 | 13 | 0 | 16.3636 | Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo | Maksimovic-Ivanic D, Mijatovic S, Harhaji L, Miljkovic D, Dabideen D, Cheng K, Mangano K, Malaponte G, Ai-Abed Y, Libra M, Garotta G, Nicoletti F, Stosic-Grujicic S | 11. | AJ387 | 2009 | E | EUROPEAN JOURNAL OF PHARMACOLOGY Vol. 615 (1-3): # 228 - 233 (6), (DOI: 10.1016/j.ejphar.2009.04.069) AUG 1 2009WOS | 12 | 7 | 11 | 0 | 3.8889 | The novel NO-donating compound GIT-27NO inhibits in vivo growth of human prostate cancer cells and prevents murine immunoinflammatory hepatitis | Donia M, Mijatovic S, Maksimovic-Ivanic D, Miljkovic D, Mangano K, Tumino S, Biondi A, Basile F, Al-Abed Y, Stosic-Grujicic S, Nicoletti F | 12. | AJ387 | 2009 | E | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL Vol. 61 (5): # 696 - 707 (12), (DOI: 10.1080/01635580902898743) 2009WOS | 66 | 42 | 9 | 0 | 30.0000 | Anticancer Properties of Ganoderma Lucidum Methanol Extracts In Vitro and In Vivo | Trajkovic L, Mijatovic S, Maksimovic-Ivanic D, Stojanovic I, Momcilovic M, Tufegdzic S, Maksimovic V, Marjanovic Z, Stosic-Grujicic S | 13. | AJ387 | 2009 | E | MOLECULAR CANCER THERAPEUTICS Vol. 8 (5): # 1169 - 1178 (10), (DOI: 10.1158/1535-7163.MCT-08-0998) MAY 2009WOS | 39 | 21 | 15 | 0 | 8.0769 | The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of Akt | Maksimovic-Ivanic D, Mijatovic S, Miljkovic D, Harhaji-Trajkovic L, Timotijevic G, Mojic M, Dabideen D, Cheng K, McCubrey J, Mangano K, Al-Abed Y, Libra M, Garotta G, Stosic-Grujicic S, Nicoletti F | 14. | AJ387 | 2010 | E | FREE RADICAL BIOLOGY AND MEDICINE Vol. 48 (8): # 1090 - 1099 (10), (DOI: 10.1016/j.freeradbiomed.2010.01.026) APR 15 2010WOS | 18 | 10 | 12 | 0 | 5.0000 | Induction of caspase-independent apoptotic-like cell death of mouse mammary tumor TA3Ha cells in vitro and reduction of their lethality in vivo by the novel chemotherapeutic agent GIT-27NO | Mijatovic S, Maksimovic-Ivanic D, Timotijevic G, Miljkovic D, Donia M, Libra M, Coco M, McCubrey J, Al-Abed Y, Korac A, Stosic-Grujicic S, Nicoletti F | 15. | AJ387 | 2011 | E | INTERNATIONAL JOURNAL OF CANCER Vol. 128 (8): # 1955 - 1965 (11), (DOI: 10.1002/ijc.25526) APR 15 2011WOS | 52 | 33 | 7 | 0 | 33.0000 | Multiple antimelanoma potential of dry olive leaf extract | Mijatovic S, Timotijevic G, Miljkovic D, Radovic J, Maksimovic-Ivanic D, Dekanski D, Stosic-Grujicic S | 16. | AJ387 | 2011 | E | JOURNAL OF CELLULAR PHYSIOLOGY Vol. 226 (7): # 1803 - 1812 (10), (DOI: 10.1002/jcp.22513) JUL 2011WOS | 28 | 16 | 12 | 0 | 8.0000 | Cytotoxic and Immune-Sensitizing Properties of Nitric Oxide-Modified Saquinavir in iNOS-Positive Human Melanoma Cells | Mijatovic S, Maksimovic-Ivanic D, Mojic M, Timotijevic G, Miljkovic D, Mangano K, Donia M, Di C, Al-Abed Y, Cheng K, Stosic-Grujicic S, Nicoletti F | 17. | AJ387 | 2011 | E | JOURNAL OF CELLULAR PHYSIOLOGY Vol. 226 (11): # 2762 - 2781 (20), (DOI: 10.1002/jcp.22647) NOV 2011WOS | 142 | 84 | 16 | 0 | 30.0000 | Therapeutic Resistance Resulting From Mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Signaling Pathways | McCubrey J, Steelman L, Kempf C, Chappell W, Abrams S, Stivala F, Malaponte G, Nicoletti F, Libra M, Bäsecke J, Maksimovic-Ivanic D, Mijatovic S, Montalto G, Cervello M, Cocco L, Martelli A | 18. | AJ387 | 2011 | E | AGING-US Vol. 3 (3): # 192 - 222 (31), (DOI: 10.18632/aging.100296) MAR 2011WOS | 538 | 374 | 25 | 0 | 81.3043 | Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging | Steelman L, Chappell W, Abrams S, Kempf C, Long J, Laidler P, Mijatovic S, Maksimovic-Ivanic D, Stivala F, Mazzarino M, Donia M, Fagone P, Malaponte G, Nicoletti F, Libra M, Milella M, Tafuri A, Bonati A, Bäsecke J, Cocco L, Evangelisti C, Martelli A, Montalto G, Cervello M, McCubrey J | 19. | AJ387 | 2011 | E | ONCOTARGET Vol. 2 (3): # 135 - 164 (30), (DOI: 10.18632/oncotarget.240) MAR 2011WOS | 491 | 314 | 26 | 0 | 65.4167 | Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health | Chappell W, Steelman L, Long J, Kempf R, Abrams S, Franklin R, Bäsecke J, Stivala F, Donia M, Fagone P, Malaponte G, Mazzarino M, Nicoletti F, Libra M, Maksimovic-Ivanic D, Mijatovic S, Montalto G, Cervello M, Laidler P, Milella M, Tafuri A, Bonati A, Evangelisti C, Cocco L, Martelli A, McCubrey J | 20. | AJ387 | 2011 | E | CELL CYCLE Vol. 10 (3): # 492 - 499 (8), (DOI: 10.4161/cc.10.3.14727) FEB 1 2011WOS | 40 | 24 | 12 | 0 | 12.0000 | In vitro and in vivo anticancer action of Saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cells | Donia M, Maksimovic-Ivanic D, Mijatovic S, Mojic M, Miljkovic D, Timotijevic G, Fagone P, Caponnetto S, Al-Abed Y, McCubrey J, Stosic-Grujicic S, Nicoletti F | 21. | AJ387 | 2012 | E | IMMUNOLOGIC RESEARCH Vol. 52 (1-2): # 157 - 168 (12), (DOI: 10.1007/s12026-012-8284-8) APR 2012WOS | 50 | 38 | 4 | 0 | 38.0000 | Resistance to TRAIL and how to surmount it | Maksimovic-Ivanic D, Stosic-Grujicic S, Nicoletti F, Mijatovic S | 22. | AJ387 | 2012 | E | FOOD AND CHEMICAL TOXICOLOGY Vol. 50 (9): # 3181 - 3189 (9), (DOI: 10.1016/j.fct.2012.05.047) SEP 2012WOS | 28 | 22 | 9 | 0 | 15.7143 | Cell-type dependent response of melanoma cells to aloe emodin | Radovic J, Maksimovic-Ivanic D, Timotijevic G, Popadic S, Ramic Z, Trajkovic V, Miljkovic D, Stosic-Grujicic S, Mijatovic S | 23. | AJ387 | 2012 | E | JOURNAL OF INORGANIC BIOCHEMISTRY Vol. 109 (): # 40 - 48 (9), (DOI: 10.1016/j.jinorgbio.2012.01.012) APR 2012WOS | 28 | 22 | 13 | 0 | 10.0000 | Novel methylene modified cyclohexyl ethylenediamine-N,N′-diacetate ligands and their platinum(IV) complexes. Influence on biological activity | Mihajlovic L, Savic A, Poljarevic J, Vuckovic I, Mojic M, Bulatovic M, Maksimovic-Ivanic D, Mijatovic S, Kaluderovic G, Stosic-Grujicic S, Miljkovic D, Grguric-Sipka S, Sabo T | 24. | AJ387 | 2012 | E | METALLOMICS Vol. 4 (9): # 979 - 987 (9), (DOI: 10.1039/c2mt20058a) 2012WOS | 37 | 29 | 12 | 0 | 14.5000 | Platinum(II/IV) complexes containing ethylenediamine-N,N′-di-2/3-propionate ester ligands induced caspase-dependent apoptosis in cisplatin-resistant colon cancer cells | Kaluderovic G, Mijatovic S, Zmejkovski B, Bulatovic M, Gómez-Ruiz S, Mojic M, Steinborn D, Miljkovic D, Schmidt H, Stosic-Grujicic S, Sabo T, Maksimovic-Ivanic D | 25. | AJ387 | 2012 | E | METALLOMICS Vol. 4 (11): # 1155 - 1159 (5), (DOI: 10.1039/c2mt20150j) NOV 2012WOS | 16 | 12 | 8 | 0 | 10.0000 | Melanoma tumor inhibition by tetrachlorido(O,O′-dibutyl-ethylenediamine-N,N′-di-3-propionate)platinum(IV) complex: in vitro and in vivo investigations | Maksimovic-Ivanic D, Mijatovic S, Mirkov I, Stosic-Grujicic S, Miljkovic D, Sabo T, Trajkovic V, Kaluderovic G | 26. | AJ387 | 2012 | E | MOLECULAR PHARMACOLOGY Vol. 82 (4): # 700 - 710 (11), (DOI: 10.1124/mol.112.077842) OCT 2012WOS | 28 | 21 | 14 | 0 | 8.7500 | Therapeutic Potential of Nitric Oxide-Modified Drugs in Colon Cancer Cells | Mojic M, Mijatovic S, Maksimovic-Ivanic D, Miljkovic D, Stosic-Grujicic S, Stankovic M, Mangano K, Travali S, Donia M, Fagone P, Zocca M, Al-Abed Y, McCubrey J, Nicoletti F | 27. | AJ387 | 2012 | E | BIOINORGANIC CHEMISTRY AND APPLICATIONS Vol. 2012 (): #140284 - (14), (DOI: 10.1155/2012/140284) 2012WOS | 134 | 113 | 4 | 0 | 113.0000 | On the Discovery, Biological Effects, and Use of Cisplatin and Metallocenes in Anticancer Chemotherapy | Gómez-Ruiz S, Maksimovic-Ivanic D, Mijatovic S, Kaluderovic G | 28. | AJ387 | 2012 | E | BIOINORGANIC CHEMISTRY AND APPLICATIONS Vol. 2012 (): #705907 - (2), (DOI: 10.1155/2012/705907) 2012WOS | 5 | 3 | 5 | 0 | 3.0000 | Metals in Medicine | Kaluderovic G, Gómez-Ruiz S, Maksimovic-Ivanic D, Paschke R, Mijatovic S | 29. | AJ387 | 2012 | E | ONCOTARGET Vol. 3 (9): # 954 - 987 (34), (DOI: 10.18632/oncotarget.652) SEP 2012WOS | 250 | 165 | 21 | 0 | 43.4211 | Mutations and Deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascades Which Alter Therapy Response. | McCubrey J, Steelman L, Chappell W, Abrams S, Montalto G, Cervello M, Nicoletti F, Fagone P, Malaponte G, Mazzarino M, Candido S, Libra M, Bäsecke J, Mijatovic S, Maksimovic-Ivanic D, Milella M, Tafuri A, Cocco L, Evangelisti C, Chiarini F, Martelli A | 30. | AJ387 | 2012 | E | ONCOTARGET Vol. 3 (10): # 1068 - 1111 (44), (DOI: 10.18632/oncotarget.659) OCT 2012WOS | 269 | 206 | 22 | 0 | 51.5000 | Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance | McCubrey J, Steelman L, Chappell W, Abrams S, Franklin R, Montalto G, Cervello M, Libra M, Candido S, Malaponte G, Mazzarino M, Fagone P, Nicoletti F, Bäsecke J, Mijatovic S, Maksimovic-Ivanic D, Milella M, Tafuri A, Chiarini F, Evangelisti C, Cocco L, Martelli A | 31. | AJ387 | 2012 | E | ONCOLOGY REPORTS Vol. 28 (2): # 682 - 688 (7), (DOI: 10.3892/or.2012.1840) AUG 2012WOS | 22 | 16 | 15 | 0 | 6.1538 | Unique antineoplastic profile of Saquinavir-NO, a novel NO-derivative of the protease inhibitor Saquinavir, on the in vitro and in vivo tumor formation of A375 human melanoma cells | Donia M, Mangano K, Fagone P, De P, Dinotta F, Coco M, Padron J, Al-Abed Y, Lombardo G, Maksimovic-Ivanic D, Mijatovic S, Zocca M, Perciavalle V, Stosic-Grujicic S, Nicoletti F | 32. | AJ387 | 2012 | E | CELL CYCLE Vol. 11 (6): # 1174 - 1182 (9), (DOI: 10.4161/cc.11.6.19611) MAR 15 2012WOS | 15 | 11 | 14 | 0 | 4.5833 | Saquinavir-NO-targeted S6 protein mediates sensitivity of androgen-dependent prostate cancer cells to TRAIL | Mojic M, Mijatovic S, Maksimovic-Ivanic D, Dinic S, Grdovic N, Miljkovic D, Stosic-Grujicic S, Tumino S, Fagone P, Mangano K, Zocca M, Al-Abed Y, McCubrey J, Nicoletti F | 33. | AJ387 | 2012 | E | CURRENT PHARMACEUTICAL DESIGN Vol. 18 (13): # 1784 - 1795 (12), (DOI: ) MAY 2012WOS | 34 | 26 | 19 | 0 | 7.6471 | Targeting the Cancer Initiating Cell: The Ultimate Target for Cancer Therapy | McCubrey J, Steelman L, Abrams S, Misaghian N, Chappell W, Bäsecke J, Nicoletti F, Libra M, Ligresti G, Stivala F, Maksi-Movic-Ivanic D, Mijatovic S, Montalto G, Cervello M, Laidler P, Bonati A, Evangelisti C, Cocco L, Martelli A | 34. | AJ387 | 2012 | E | ONCOTARGET Vol. 3 (12): # 1505 - 1521 (17), (DOI: ) DEC 2012WOS | 37 | 29 | 34 | 0 | 4.5312 | Advances in Targeting Signal Transduction Pathways | McCubrey J, Steelman L, Chappell W, Sun L, Davis N, Abrams S, Franklin R, Cocco L, Evangelisti C, Chiarini F, Martelli A, Libra M, Candido S, Ligresti G, Malaponte G, Mazzarino M, Fagone P, Donia M, Nicoletti F, Polesel J, Talamini R, Bäsecke J, Mijatovic S, Maksimovic-Ivanic D, Milella M, Tafuri A, Dulinska-Litewka J, Laidler P, D'Assoro A, Drobot L, ... | 35. | AJ387 | 2013 | E | JOURNAL OF MEMBRANE BIOLOGY Vol. 246 (4): # 307 - 314 (8), (DOI: 10.1007/s00232-013-9531-1) APR 2013WOS | 22 | 18 | 7 | 0 | 18.0000 | Membrane Fluidity, Invasiveness and Dynamic Phenotype of Metastatic Prostate Cancer Cells after Treatment with Soy Isoflavones | Ajdzanovic V, Mojic M, Maksimovic-Ivanic D, Bulatovic M, Mijatovic S, Milosevic V, Spasojevic I | 36. | AJ387 | 2013 | E | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY Vol. 69 (): # 216 - 222 (7), (DOI: 10.1016/j.ejmech.2013.08.025) NOV 2013WOS | 28 | 24 | 10 | 0 | 15.0000 | Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph2PCH2S(O)xPh (x=0-2) ligands | Ludwig G, Mijatovic S, Randelovic I, Bulatovic M, Miljkovic D, Maksimovic-Ivanic D, Korb M, Lang H, Steinborn D, Kaluderovic G | 37. | AJ387 | 2013 | E | JOURNAL OF NEUROIMMUNOLOGY Vol. 259 (1-2): # 55 - 65 (11), (DOI: 10.1016/j.jneuroim.2013.03.010) JUN 15 2013WOS | 9 | 6 | 12 | 0 | 3.0000 | Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis | Petkovic F, Blazevski J, Momcilovic M, Timotijevic G, Zocca M, Mijatovic S, Maksimovic-Ivanic D, Mangano K, Fagone P, Stosic-Grujicic S, Nicoletti F, Miljkovic D | 38. | AJ387 | 2013 | E | JOURNAL OF NEUROIMMUNOLOGY Vol. 262 (1-2): # 72 - 78 (7), (DOI: 10.1016/j.jneuroim.2013.07.001) SEP 15 2013WOS | 8 | 8 | 13 | 0 | 3.6364 | Apotransferrin inhibits interleukin-2 expression and protects mice from experimental autoimmune encephalomyelitis | Saksida T, Miljkovic D, Timotijevic G, Stojanovic I, Mijatovic S, Fagone P, Mangano K, Mammana S, Farina C, Ascione E, Maiello V, Nicoletti F, Stosic-Grujicic S | 39. | AJ387 | 2013 | E | JOURNAL OF MEDICAL BIOCHEMISTRY Vol. 32 (4): # 406 - 416 (11), (DOI: 10.2478/jomb-2013-0050) OCT 2013WOS | 2 | 2 | 11 | 0 | 1.1111 | NO-MODIFIED SAQUINAVIR IS EQUALLY EFFICIENT AGAINST DOXORUBICIN SENSITIVE AND RESISTANT NON-SMALL CELL LUNG CARCINOMA CELLS | Mijatovic S, Pesic M, Mojic M, Bankovic J, Miljkovic D, Fagone P, Mangano K, Nicoletti F, McCubrey J, Tanic N, Maksimovic-Ivanic D | 40. | AJ387 | 2013 | E | DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES Vol. 8 (2): # 877 - U461 (10), (DOI: ) APR-JUN 2013WOS | 3 | 3 | 10 | 0 | 1.8750 | IN VITRO ASSESSMENT OF Ni-Cr AND Co-Cr DENTAL ALLOYS UPON RECASTING: CELLULAR COMPATIBILITY | Cairovic A, Djordjevic I, Bulatovic M, Mojic M, Momcilovic M, Stosic-Grujicic S, Maksimovic V, Maksimovic-Ivanic D, Mijatovic S, Stamenkovic D | 41. | AJ387 | 2014 | E | ANGEWANDTE CHEMIE-INTERNATIONAL EDITION Vol. 53 (23): # 5982 - 5987 (6), (DOI: 10.1002/anie.201400763) JUN 2014WOS | 90 | 84 | 13 | 0 | 38.1818 | Organotin(IV)-Loaded Mesoporous Silica as a Biocompatible Strategy in Cancer Treatment | Bulatovic M, Maksimovic-Ivanic D, Bensing C, Gómez-Ruiz S, Steinborn D, Schmidt H, Mojic M, Korac A, Golic I, Pérez-Quintanilla D, Momcilovic M, Mijatovic S, Kaluderovic G | 42. | AJ387 | 2014 | E | CHEMMEDCHEM Vol. 9 (7): # 1586 - 1593 (8), (DOI: 10.1002/cmdc.201300479) JUL 2014WOS | 16 | 15 | 10 | 0 | 9.3750 | Anticancer Potential of (Pentamethylcyclopentadienyl)chloridoiridium(III) Complexes Bearing κP and κP,κS-Coordinated Ph2PCH2CH2CH2S(O)xPh (x=0-2) Ligands | Ludwig G, Randelovic I, Maksimovic-Ivanic D, Mijatovic S, Bulatovic M, Miljkovic D, Korb M, Lang H, Steinborn D, Kaluderovic G | 43. | AJ387 | 2014 | E | JOURNAL OF ORGANOMETALLIC CHEMISTRY Vol. 751 (): # 361 - 367 (7), (DOI: 10.1016/j.jorganchem.2013.07.059) FEB 1 2014WOS | 11 | 9 | 10 | 0 | 5.6250 | Study of the anticancer properties of methyl- and phenyl-substituted carbon- and silicon-bridged ansa-titanocene complexes | Mijatovic S, Bulatovic M, Mojic M, Stosic-Grujicic S, Miljkovic D, Maksimovic-Ivanic D, Gómez-Ruiz S, Pinkas J, Horácek M, Kaluderovic G | 44. | AJ387 | 2014 | E | JOURNAL OF ORGANOMETALLIC CHEMISTRY Vol. 749 (): # 142 - 149 (8), (DOI: 10.1016/j.jorganchem.2013.08.041) JAN 1 2014WOS | 9 | 7 | 10 | 0 | 4.3750 | Synthesis, X-ray structure and strong in vitro cytotoxicity of novel organoruthenium complexes | Mojic M, Savic A, Arion V, Bulatovic M, Poljarevic J, Miljkovic D, Sabo T, Mijatovic S, Maksimovic-Ivanic D, Grguric-Sipka S | 45. | AJ387 | 2014 | E | JOURNAL OF ORGANOMETALLIC CHEMISTRY Vol. 769 (): # 46 - 57 (12), (DOI: 10.1016/j.jorganchem.2014.06.031) OCT 15 2014WOS | 6 | 6 | 8 | 0 | 5.0000 | Alkenyl-substituted titanocene dichloride complexes: Stability studies, binding and cytotoxicity | Ceballos-Torres J, del H, Prashar S, Fajardo M, Mijatovic S, Maksimovic-Ivanic D, Kaluderovic G, Gómez-Ruiz S | 46. | AJ387 | 2014 | E | SCIENTIFIC REPORTS Vol. 4 (): #5955 - (8), (DOI: 10.1038/srep05955) AUG 5 2014WOS | 56 | 52 | 7 | 0 | 52.0000 | Extracellular iron diminishes anticancer effects of vitamin C: An in vitro study | Mojic M, Pristov J, Maksimovic-Ivanic D, Jones D, Stanic M, Mijatovic S, Spasojevic I | 47. | AJ387 | 2014 | E | JOURNAL OF MATERIALS CHEMISTRY B Vol. 2 (21): # 3271 - 3281 (11), (DOI: 10.1039/c4tb00300d) 2014WOS | 13 | 12 | 8 | 0 | 10.0000 | Undecylprodigiosin conjugated monodisperse gold nanoparticles efficiently cause apoptosis in colon cancer cells in vitro | Nikodinovic-Runic J, Mojic M, Kang Y, Maksimovic-Ivanic D, Mijatovic S, Vasiljevic B, Stamenkovic V, Senerovic L | 48. | AJ387 | 2014 | E | CELLS TISSUES ORGANS Vol. 200 (3-4): # 265 - 277 (13), (DOI: 10.1159/000434625) 2014WOS | 38 | 37 | 6 | 0 | 37.0000 | A Key Role of Autophagy in Osteoblast Differentiation on Titanium-Based Dental Implants | Kaluderovic M, Mojic M, Schreckenbach J, Maksimovic-Ivanic D, Graf H, Mijatovic S | 49. | AJ387 | 2014 | E | ONCOTARGET Vol. 5 (13): # 4603 - 4650 (48), (DOI: 10.18632/oncotarget.2209) JUL 15 2014WOS | 203 | 190 | 26 | 0 | 39.5833 | Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention | Davis N, Sokolosky M, Stadelman K, Abrams S, Libra M, Candido S, Nicoletti F, Polesel J, Maestro R, D'Assoro A, Drobot L, Rakus D, Gizak A, Laidler P, Dulinska-Litewka J, Basecke J, Mijatovic S, Maksimovic-Ivanic D, Montalto G, Cervello M, Fitzgerald T, Demidenko Z, Martelli A, Cocco L, Steelman L, McCubrey J | 50. | AJ387 | 2015 | E | APPLIED ORGANOMETALLIC CHEMISTRY Vol. 29 (1): # 20 - 25 (6), (DOI: 10.1002/aoc.3238) JAN 2015WOS | 9 | 8 | 8 | 0 | 6.6667 | Binuclear dichlorido(η6-p-cymene)ruthenium(II) complexes with bis(nicotinate)- and bis (isonicotinate)-polyethylene glycol ester ligands | Eichhorn T, Hey-Hawkins E, Maksimovic-Ivanic D, Mojic M, Schmidt J, Mijatovic S, Schmidt H, Kaluderovic G | 51. | AJ387 | 2015 | E | EUROPEAN JOURNAL OF PHARMACOLOGY Vol. 760 (): # 136 - 144 (9), (DOI: 10.1016/j.ejphar.2015.04.012) AUG 5 2015WOS | 9 | 9 | 10 | 0 | 5.6250 | Improved in vitro antitumor potential of (O,O'-Diisobutyl-ethylenediamine-N,N'-di-3-propionate)tetrachloridoplatinum(IV) complex under normoxic and hypoxic conditions | Bulatovic M, Kaluderovic M, Mojic M, Zmejkovski B, Hey-Hawkins E, Vidakovic M, Grdovic N, Kaluderovic G, Mijatovic S, Maksimovic-Ivanic D | 52. | AJ387 | 2015 | E | JOURNAL OF INORGANIC BIOCHEMISTRY Vol. 153 (): # 315 - 321 (7), (DOI: 10.1016/j.jinorgbio.2015.09.006) DEC 2015WOS | 32 | 30 | 7 | 0 | 30.0000 | Ruthenium(II) p-cymene complex bearing 2,2′-dipyridylamine targets caspase 3 deficient MCF-7 breast cancer cells without disruption of antitumor immune response | Kaluderovic G, Krajnovic T, Momcilovic M, Stosic-Grujicic S, Mijatovic S, Maksimovic-Ivanic D, Hey-Hawkins E | 53. | AJ387 | 2015 | E | LEUKEMIA RESEARCH Vol. 39 (10): # 1088 - 1095 (8), (DOI: 10.1016/j.leukres.2015.06.013) OCT 2015WOS | 25 | 25 | 14 | 0 | 10.4167 | The NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: Role of p70S6K | Maksimovic-Ivanic D, Mojic M, Bulatovic M, Radojkovic M, Kuzmanovic M, Ristic S, Stosic-Grujicic S, Miljkovic D, Cavalli E, Libra M, Fagone P, McCubrey J, Nicoletti F, Mijatovic S | 54. | AJ387 | 2016 | E | PHARMACOLOGICAL RESEARCH Vol. 105 (): # 62 - 73 (12), (DOI: 10.1016/j.phrs.2016.01.011) MAR 2016WOS | 70 | 64 | 5 | 0 | 64.0000 | Versatile antitumor potential of isoxanthohumol: Enhancement of paclitaxel activity in vivo | Krajnovic T, Kaluderovic G, Wessjohann L, Mijatovic S, Maksimovic-Ivanic D | 55. | AJ387 | 2016 | E | DALTON TRANSACTIONS Vol. 45 (33): # 13114 - 13125 (12), (DOI: 10.1039/c6dt01782g) SEP 7 2016WOS | 34 | 32 | 10 | 0 | 20.0000 | Antiproliferative activity of ruthenium(II) arene complexes with mono- and bidentate pyridine-based ligands | Richter S, Singh S, Draca D, Kate A, Kumbhar A, Kumbhar A, Maksimovic-Ivanic D, Mijatovic S, Lönnecke P, Hey-Hawkins E | 56. | AJ387 | 2016 | E | DALTON TRANSACTIONS Vol. 45 (47): # 18984 - 18993 (10), (DOI: 10.1039/c6dt03519a) DEC 21 2016WOS | 34 | 31 | 8 | 0 | 25.8333 | Evaluation of functionalized mesoporous silica SBA-15 as a carrier system for Ph3Sn(CH2)3OH against the A2780 ovarian carcinoma cell line | Bensing C, Mojic M, Gómez-Ruiz S, Carralero S, Doloinovic B, Maksimovic-Ivanic D, Mijatovic S, Kaluderovic G | 57. | AJ387 | 2016 | E | MOLECULAR BIOLOGY Vol. 50 (1): # 153 - 156 (4), (DOI: 10.1134/S002689331601012X) JAN 2016WOS | 3 | 2 | 7 | 0 | 2.0000 | ALPHA-1 Antitrypsin Affects U0126-Induced Cytotoxicity in Colon Cancer Cell Line (HCT116) | Ljujic M, Mijatovic S, Bulatovic M, Mojic M, Maksimovic-Ivanic D, Radojkovic D, Topic A | 58. | AJ387 | 2016 | E | CURRENT PHARMACEUTICAL DESIGN Vol. 22 (16): # 2358 - 2388 (31), (DOI: 10.2174/1381612822666160304151011) 2016WOS | 36 | 30 | 28 | 0 | 5.7692 | Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy | Steelman L, Fitzgerald T, Lertpiriyapong K, Cocco L, Follo M, Martelli A, Neri L, Marmiroli S, Libra M, Candido S, Nicoletti F, Scalisi A, Fenga C, Drobot L, Rakus D, Gizak A, Laidler P, Dulinska-Litewka J, Basecke J, Mijatovic S, Maksimovic-Ivanic D, Montalto G, Cervello M, Milella M, Tafuri A, Demidenko Z, Abrams S, McCubrey J | 59. | AJ387 | 2016 | E | ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY Vol. 16 (3): # 359 - 364 (6), (DOI: 10.2174/1871520615666151007160319) 2016WOS | 11 | 11 | 5 | 0 | 11.0000 | Anticancer Activity of Organogallium(III) Complexes in Colon Cancer Cells | Kaluderovic M, Mojic M, Gómez-Ruiz S, Mijatovic S, Maksimovic-Ivanic D | 60. | AJ387 | 2016 | E | ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY Vol. 16 (11): # 1455 - 1460 (6), (DOI: 10.2174/1871520615666151029100749) 2016WOS | 10 | 9 | 7 | 0 | 9.0000 | Biological Potential of Halfsandwich Ruthenium(II) and Iridium (III) Complexes | Ludwig G, Mojic M, Bulatovic M, Mijatovic S, Maksimovic-Ivanic D, Steinborn D, Kaluderovic G | 61. | AJ387 | 2017 | E | CHEMMEDCHEM Vol. 12 (13): # 1081 - 1086 (6), (DOI: 10.1002/cmdc.201700309) JUL 6 2017WOS | 16 | 15 | 10 | 0 | 9.3750 | CarbORev-5901: The First Carborane-Based Inhibitor of the 5-Lipoxygenase Pathway | Kuhnert R, Sárosi M, George S, Lönnecke P, Hofmann B, Steinhilber D, Murganic B, Mijatovic S, Maksimovic-Ivanic D, Hey-Hawkins E | 62. | AJ387 | 2017 | E | INTERNATIONAL JOURNAL OF CANCER Vol. 140 (8): # 1713 - 1726 (14), (DOI: 10.1002/ijc.30529) APR 2017WOS | 70 | 66 | 6 | 0 | 66.0000 | HIV-protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives? | Maksimovic-Ivanic D, Fagone P, McCubrey J, Bendtzen K, Mijatovic S, Nicoletti F | 63. | AJ387 | 2017 | E | PATHOLOGY & ONCOLOGY RESEARCH Vol. 23 (2): # 335 - 343 (9), (DOI: 10.1007/s12253-016-0104-3) APR 2017WOS | 4 | 4 | 7 | 0 | 4.0000 | Alpha-1-Antitrypsin Antagonizes Cisplatin-Induced Cytotoxicity in Prostate Cancer (PC3) and Melanoma Cancer (A375) Cell Lines | Ljujic M, Mijatovic S, Bulatovic M, Mojic M, Maksimovic-Ivanic D, Radojkovic D, Topic A | 64. | AJ387 | 2017 | E | DALTON TRANSACTIONS Vol. 46 (36): # 12067 - 12080 (14), (DOI: 10.1039/c7dt02027a) SEP 28 2017WOS | 17 | 16 | 8 | 0 | 13.3333 | Antiproliferative activity of (η6-arene)-ruthenacarborane sandwich complexes against HCT116 and MCF7 cell lines | Gozzi M, Schwarze B, Sárosi M, Lönnecke P, Draca D, Maksimovic-Ivanic D, Mijatovic S, Hey-Hawkins E | 65. | AJ387 | 2017 | E | COATINGS Vol. 7 (7): #102 - (18), (DOI: 10.3390/coatings7070102) JUL 2017WOS | 13 | 11 | 5 | 0 | 11.0000 | Ti-SLActive and TiZr-SLActive Dental Implant Surfaces Promote Fast Osteoblast Differentiation | Kaluderovic M, Krajnovic T, Maksimovic-Ivanic D, Graf H, Mijatovic S | 66. | AJ387 | 2017 | E | INORGANICS Vol. 5 (3): #56 - (13), (DOI: 10.3390/inorganics5030056) SEP 2017WOS | 2 | 2 | 7 | 0 | 2.0000 | (18-Crown-6)potassium(I) Trichlorido[28-acetyl-3-(tris-(hydroxylmethyl)amino-ethane)betulinic ester-N]platinum(II): Synthesis and In Vitro Antitumor Activity | Kaluderovic G, Bulatovic M, Krajnovic T, Paschke R, Zmejkovski B, Maksimovic-Ivanic D, Mijatovic S | 67. | AJ387 | 2018 | E | BIOTECHNOLOGY ADVANCES Vol. 36 (6): # 1622 - 1632 (11), (DOI: 10.1016/j.biotechadv.2018.04.001) NOV 1 2018WOS | 42 | 37 | 6 | 0 | 37.0000 | Naturally occurring compounds in differentiation based therapy of cancer | Mijatovic S, Bramanti A, Nicoletti F, Fagone P, Kaluderovic G, Maksimovic-Ivanic D | 68. | AJ387 | 2018 | E | JOURNAL OF INORGANIC BIOCHEMISTRY Vol. 180 (): # 155 - 162 (8), (DOI: 10.1016/j.jinorgbio.2017.12.011) MAR 2018WOS | 16 | 15 | 8 | 0 | 12.5000 | Delivery of [Ru(η6-p-cymene)Cl2{Ph2P(CH2)3SPh-1κP}] using unfunctionalized and mercapto functionalized SBA-15 mesoporous silica: Preparation, characterization and in vitro study | Edeler D, Arlt S, Petkovic V, Ludwig G, Draca D, Maksimovic-Ivanic D, Mijatovic S, Kaluderovic G | 69. | AJ387 | 2018 | E | MOLECULES Vol. 23 (10): #2463 - (16), (DOI: 10.3390/molecules23102463) OCT 2018WOS | 37 | 37 | 10 | 0 | 23.1250 | Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells | Basile M, Mazzon E, Krajnovic T, Draca D, Cavalli E, Al-Abed Y, Bramanti P, Nicoletti F, Mijatovic S, Maksimovic-Ivanic D | 70. | AJ387 | 2018 | E | NANOMATERIALS Vol. 8 (5): #322 - (16), (DOI: 10.3390/nano8050322) MAY 2018WOS | 28 | 25 | 8 | 0 | 20.8333 | Drug Delivery System for Emodin Based on Mesoporous Silica SBA-15 | Krajnovic T, Maksimovic-Ivanic D, Mijatovic S, Draca D, Wolf K, Edeler D, Wessjohann L, Kaluderovic G | 71. | AJ387 | 2019 | E | CHEMMEDCHEM Vol. 14 (2): # 255 - 261 (7), (DOI: 10.1002/cmdc.201800651) JAN 22 2019WOS | 19 | 18 | 12 | 0 | 9.0000 | Carborane-Based Analogues of 5-Lipoxygenase Inhibitors Co-inhibit Heat Shock Protein 90 in HCT116 Cells | Kuhnert R, Sárosi M, George S, Lönnecke P, Hofmann B, Steinhilber D, Steinmann S, Schneider-Stock R, Murganic B, Mijatovic S, Maksimovic-Ivanic D, Hey-Hawkins E | 72. | AJ387 | 2019 | E | CHEMMEDCHEM Vol. 14 (3): # 315 - 321 (7), (DOI: 10.1002/cmdc.201800685) FEB 5 2019WOS | 27 | 21 | 10 | 0 | 13.1250 | Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines | Buzharevski A, Paskas S, Sárosi M, Laube M, Lönnecke P, Neumann W, Mijatovic S, Maksimovic-Ivanic D, Pietzsch J, Hey-Hawkins E | 73. | AJ387 | 2019 | E | CHEMMEDCHEM Vol. 14 (24): # 2061 - 2074 (14), (DOI: 10.1002/cmdc.201900349) DEC 17 2019WOS | 11 | 9 | 8 | 0 | 7.5000 | Quinoline-Conjugated Ruthenacarboranes: Toward Hybrid Drugs with a Dual Mode of Action | Gozzi M, Murganic B, Draca D, Popp J, Coburger P, Maksimovic-Ivanic D, Mijatovic S, Hey-Hawkins E | 74. | AJ387 | 2019 | E | CHEMMEDCHEM Vol. 14 (24): # 2075 - 2083 (9), (DOI: 10.1002/cmdc.201900554) DEC 17 2019WOS | 13 | 12 | 6 | 0 | 12.0000 | 2,2'-Bipyridine-Modified Tamoxifen: A Versatile Vector for Molybdacarboranes | Schwarze B, Jelaca S, Welcke L, Maksimovic-Ivanic D, Mijatovic S, Hey-Hawkins E | 75. | AJ387 | 2019 | E | MOLECULAR CARCINOGENESIS Vol. 58 (8): # 1362 - 1375 (14), (DOI: 10.1002/mc.23020) AUG 2019WOS | 18 | 18 | 11 | 0 | 10.0000 | Senescence as a main mechanism of Ritonavir and Ritonavir-NO action against melanoma | Paskas S, Krajnovic T, Basile M, Dunderovic D, Cavalli E, Mangano K, Mammana S, Al-Abed Y, Nicoletti F, Mijatovic S, Maksimovic-Ivanic D | 76. | AJ387 | 2019 | E | JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY Vol. 24 (2): # 223 - 234 (12), (DOI: 10.1007/s00775-019-01640-x) MAR 2019WOS | 26 | 22 | 8 | 0 | 18.3333 | The interaction between SBA-15 derivative loaded with Ph3Sn(CH2)6OH and human melanoma A375 cell line: uptake and stem phenotype loss | Maksimovic-Ivanic D, Bulatovic M, Edeler D, Bensing C, Golic I, Korac A, Kaluderovic G, Mijatovic S | 77. | AJ387 | 2019 | E | INVESTIGATIONAL NEW DRUGS Vol. 37 (5): # 1014 - 1028 (15), (DOI: 10.1007/s10637-019-00733-3) OCT 2019WOS | 44 | 42 | 10 | 0 | 26.2500 | Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo | Paskas S, Mazzon E, Basile M, Cavalli E, Al-Abed Y, He M, Rakocevic S, Nicoletti F, Mijatovic S, Maksimovic-Ivanic D | 78. | AJ387 | 2019 | E | FOOD AND CHEMICAL TOXICOLOGY Vol. 129 (): # 257 - 268 (12), (DOI: 10.1016/j.fct.2019.04.046) JUL 2019WOS | 19 | 17 | 8 | 0 | 14.1667 | The hop-derived prenylflavonoid isoxanthohumol inhibits the formation of lung metastasis in B16-F10 murine melanoma model | Krajnovic T, Draca D, Kaluderovic G, Dunderovic D, Mirkov I, Wessjohann L, Maksimovic-Ivanic D, Mijatovic S | 79. | AJ387 | 2019 | E | MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS Vol. 100 (): # 315 - 322 (8), (DOI: 10.1016/j.msec.2019.03.010) JUL 2019WOS | 16 | 13 | 8 | 0 | 10.8333 | Impact of the mesoporous silica SBA-15 functionalization on the mode of action of Ph3Sn(CH2)6OH | Edeler D, Draca D, Petkovic V, Natalio F, Maksimovic-Ivanic D, Mijatovic S, Schmidt H, Kaluderovic G | 80. | AJ387 | 2019 | E | EXPERIMENTAL CELL RESEARCH Vol. 380 (2): # 159 - 170 (12), (DOI: 10.1016/j.yexcr.2019.04.028) JUL 15 2019WOS | 9 | 8 | 8 | 0 | 6.6667 | The synthetic tubulysin derivative, tubugi-1, improves the innate immune response by macrophage polarization in addition to its direct cytotoxic effects in a murine melanoma model | Draca D, Mijatovic S, Krajnovic T, Pristov J, Dukic T, Kaluderovic G, Wessjohann L, Maksimovic-Ivanic D | 81. | AJ387 | 2019 | E | ACS OMEGA Vol. 4 (5): # 8824 - 8833 (10), (DOI: 10.1021/acsomega.9b00412) MAY 2019WOS | 18 | 12 | 10 | 0 | 7.5000 | Carboranyl Analogues of Ketoprofen with Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines | Buzharevski A, Paskas S, Laube M, Lösnnecke P, Neumann W, Murganic B, Mijatovic S, Maksimovic-Ivanic D, Pietzsch J, Hey-Hawkins E | 82. | AJ387 | 2019 | E | EXCLI JOURNAL Vol. 18 (): # 106 - 126 (21), (DOI: 10.17179/excli2018-1836) 2019WOS | 13 | 11 | 8 | 0 | 9.1667 | PROSTATE CANCER METASTASIS AND SOY ISOFLAVONES: A DOGFIGHT OVER A BONE | Ajdzanovic V, Filipovic B, Miljic D, Mijatovic S, Maksimovic-Ivanic D, Miler M, Zivanovic J, Milosevic V | 83. | AJ387 | 2019 | E | ANTICANCER RESEARCH Vol. 39 (10): # 5403 - 5415 (13), (DOI: 10.21873/anticanres.13734) OCT 2019WOS | 5 | 3 | 6 | 0 | 3.0000 | Synthetic Tubulysin Derivative, Tubugi-1, Against Invasive Melanoma Cells: The Cell Death Triangle | Draca D, Mijatovic S, Krajnovic T, Kaluderovic G, Wessjohann L, Maksimovic-Ivanic D | 84. | AJ387 | 2020 | M21a | E | Article | SCIENTIFIC REPORTS Vol. 10 (1): #4827 - (13), (DOI: 10.1038/s41598-020-59059-3) MAR 16 2020WOS | 18 | 15 | 11 | 6.6667 | 8.3333 | Carboranyl Derivatives of Rofecoxib with Cytostatic Activity against Human Melanoma and Colon Cancer Cells | Buzharevski A, Paskas S, Sárosi M, Laube M, Lönnecke P, Neumann W, Murganic B, Mijatovic S, Maksimovic-Ivanic D, Pietzsch J, Hey-Hawkins E | 85. | AJ387 | 2020 | M21a | E | Review | ANTIOXIDANTS Vol. 9 (5): #374 - (26), (DOI: 10.3390/antiox9050374) MAY 2020WOS | 93 | 81 | 6 | 12.0000 | 81.0000 | The Double-Faced Role of Nitric Oxide and Reactive Oxygen Species in Solid Tumors | Mijatovic S, Savic-Radojevic A, Pljesa-Ercegovac M, Simic T, Nicoletti F, Maksimovic-Ivanic D | 86. | AJ387 | 2021 | M21a | E | Article | JOURNAL OF INORGANIC BIOCHEMISTRY Vol. 217 (): #111383 - (10), (DOI: 10.1016/j.jinorgbio.2021.111383) APR 2021WOS | 20 | 16 | 9 | 8.5714 | 11.4286 | Antitumor potential of cisplatin loaded into SBA-15 mesoporous silica nanoparticles against B16F1 melanoma cells: in vitro and in vivo studies | Draca D, Edeler D, Saoud M, Dojcinovic B, Dunderovic D, Dmura G, Maksimovic-Ivanic D, Mijatovic S, Kaluderovic G | 87. | AJ387 | 2021 | M21a | E | Article | MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS Vol. 124 (): #112078 - (9), (DOI: 10.1016/j.msec.2021.112078) MAY 2021WOS | 50 | 36 | 12 | 6.0000 | 18.0000 | Development of genistein-loaded gold nanoparticles and their antitumor potential against prostate cancer cell lines | Vodnik V, Mojic M, Stamenovic U, Otonicar M, Ajdzanovic V, Maksimovic-Ivanic D, Mijatovic S, Markovic M, Barudzija T, Filipovic B, Milosevic V, Sosic-Jurjevic B | 88. | AJ387 | 2021 | M21 | E | Article | BIOMOLECULES Vol. 11 (2): #154 - (15), (DOI: 10.3390/biom11020154) FEB 2021WOS | 18 | 12 | 13 | 3.6364 | 5.4545 | The Middle Part of the Plucked Hair Follicle Outer Root Sheath Is Identified as an Area Rich in Lineage-Specific Stem Cell Markers | Li H, Masieri F, Schneider M, Bartella A, Gaus S, Hahnel S, Zimmerer R, Sack U, Maksimovic-Ivanic D, Mijatovic S, Simon J, Lethaus B, Savkovic V | 89. | AJ387 | 2021 | M21 | E | Article | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES Vol. 22 (14): #7422 - (18), (DOI: 10.3390/ijms22147422) JUL 2021WOS | 15 | 11 | 8 | 6.6667 | 9.1667 | A Comparative Analysis of the In Vitro Anticancer Activity of Iridium(III) {η5-C5Me4R} Complexes with Variable R Groups | De P, Draca D, Murrali M, Zacchini S, Pampaloni G, Mijatovic S, Maksimovic-Ivanic D, Marchetti F | 90. | AJ387 | 2021 | M21 | E | Article | MOLECULES Vol. 26 (7): #1860 - (15), (DOI: 10.3390/molecules26071860) APR 2021WOS | 6 | 4 | 9 | 5.7143 | 2.8571 | Arene Ruthenium(II) Complexes Bearing the κ-P or κ-P,κ-S Ph2P(CH2)3SPh Ligand | Arlt S, Petkovic V, Ludwig G, Eichhorn T, Lang H, Rüffer T, Mijatovic S, Maksimovic-Ivanic D, Kaluderovic G | 91. | AJ387 | 2021 | M21 | E | Article | MOLECULES Vol. 26 (13): #3801 - (10), (DOI: 10.3390/molecules26133801) JUL 2021WOS | 6 | 5 | 6 | 8.0000 | 5.0000 | Ruthenacarborane and Quinoline: A Promising Combination for the Treatment of Brain Tumors | Draca D, Markovic M, Gozzi M, Mijatovic S, Maksimovic-Ivanic D, Hey-Hawkins E | 92. | AJ387 | 2022 | M21a | E | Article | MATERIALS Vol. 15 (14): #5028 - (13), (DOI: 10.3390/ma15145028) JUL 2022WOS | 9 | 5 | 8 | 10.0000 | 4.1667 | Anticancer Potential of Xanthohumol and Isoxanthohumol Loaded into SBA-15 Mesoporous Silica Particles against B16F10 Melanoma Cells | Krajnovic T, Pantelic N, Wolf K, Eichhorn T, Maksimovic-Ivanic D, Mijatovic S, Wessjohann L, Kaluderovic G | 93. | AJ387 | 2022 | M21 | E | Article | CHEMMEDCHEM Vol. 17 (1): # - (8), (DOI: 10.1002/cmdc.202100588) JAN 5 2022WOS | 11 | 10 | 12 | 4.0000 | 5.0000 | Borcalein: a Carborane-Based Analogue of Baicalein with 12-Lipoxygenase-Independent Toxicity | Kuhnert R, Kuhnert L, Sárosi M, George S, Draca D, Paskas S, Hofmann B, Steinhilber D, Honscha W, Mijatovic S, Maksimovic-Ivanic D, Hey-Hawkins E | 94. | AJ387 | 2022 | M21 | E | Article | STEM CELL REVIEWS AND REPORTS Vol. 18 (6): # 2028 - 2044 (17), (DOI: 10.1007/s12015-021-10288-7) AUG 2022WOS | 26 | 19 | 14 | 3.3333 | 7.9167 | Mesenchymal Stem Cells From Mouse Hair Follicles Reduce Hypertrophic Scarring in a Murine Wound Healing Model | Li H, Ziemer M, Stojanovic I, Saksida T, Maksimovic-Ivanic D, Mijatovic S, Djmura G, Gajic D, Koprivica I, Krajnovic T, Draca D, Simon J, Lethaus B, Savkovic V | 95. | AJ387 | 2022 | M21 | E | Article | ACS OMEGA Vol. 7 (28): # 24282 - 24291 (10), (DOI: 10.1021/acsomega.2c01523) JUL 19 2022WOS | 24 | 17 | 10 | 5.0000 | 10.6250 | Carboranyl Analogues of Mefenamic Acid and Their Biological Evaluation | Useini L, Mojic M, Laube M, Loennecke P, Dahme J, Sarosi M, Mijatovic S, Maksimovic-Ivanic D, Pietzsch J, Hey-Hawkins E | 96. | AJ387 | 2022 | M21 | E | Article | MOLECULES Vol. 27 (14): #4503 - (10), (DOI: 10.3390/molecules27144503) JUL 2022WOS | 2 | 2 | 6 | 8.0000 | 2.0000 | Carborane-Based Analog of Rev-5901 Attenuates Growth of Colon Carcinoma In Vivo | Paskas S, Murganic B, Kuhnert R, Hey-Hawkins E, Mijatovic S, Maksimovic-Ivanic D | 97. | AJ387 | 2022 | M21 | E | Article | MOLECULES Vol. 27 (23): #8113 - (20), (DOI: 10.3390/molecules27238113) DEC 2022WOS | 12 | 7 | 12 | 4.0000 | 3.5000 | Beyond Traditional Use of Alchemilla vulgaris: Genoprotective and Antitumor Activity In Vitro | Jelaca S, Dajic-Stevanovic Z, Vukovic N, Kolasinac S, Trendafilova A, Nedialkov P, Stankovic M, Tanic N, Tanic N, Acovic A, Mijatovic S, Maksimovic-Ivanic D | 98. | AJ387 | 2022 | M21 | E | Article | NANOMATERIALS Vol. 12 (8): #1331 - (18), (DOI: 10.3390/nano12081331) APR 2022WOS | 10 | 9 | 8 | 6.6667 | 7.5000 | Combined Action of Hyper-Harmonized Hydroxylated Fullerene Water Complex and Hyperpolarized Light Leads to Melanoma Cell Reprogramming In Vitro | Markelic M, Draca D, Krajnovic T, Jovic Z, Vuksanovic M, Koruga D, Mijatovic S, Maksimovic-Ivanic D | 99. | AJ387 | 2022 | M21 | E | Article | NANOMATERIALS Vol. 12 (21): #3767 - (23), (DOI: 10.3390/nano12213767) NOV 2022WOS | 21 | 13 | 12 | 4.0000 | 6.5000 | Mesoporous Silica Nanoparticles Enhance the Anticancer Efficacy of Platinum(IV)-Phenolate Conjugates in Breast Cancer Cell Lines | Predarska I, Saoud M, Draca D, Morgan I, Komazec T, Eichhorn T, Mihajlovic E, Dunderovic D, Mijatovic S, Maksimovic-Ivanic D, Hey-Hawkins E, Kaluderovic G | 100. | AJ387 | 2022 | M23 | E | Article | BIOMATERIALS ADVANCES Vol. 140 (): #213054 - (8), (DOI: 10.1016/j.bioadv.2022.213054) SEP 2022WOS | 5 | 3 | 9 | 2.1429 | 2.1429 | Effect of chain length on the cytotoxic activity of (alkyl-ω-ol)triphenyltin(IV) loaded into SBA-15 nanostructured silica and in vivo study of SBA-15∼Cl|Ph3Sn(CH2)8OH | Bensing C, Mojic M, Bulatovic M, Edeler D, Pérez-Quintanilla D, Gómez-Ruiz S, Maksimovic-Ivanic D, Mijatovic S, Kaluderovic G | 101. | AJ387 | 2023 | M21a | E | Article | PHARMACEUTICALS Vol. 16 (11): #1582 - (12), (DOI: 10.3390/ph16111582) NOV 2023WOS | 2 | 0 | 7 | 12.0000 | 0.0000 | Carborane-Based ABCG2-Inhibitors Sensitize ABC-(Over)Expressing Cancer Cell Lines for Doxorubicin and Cisplatin | Paskas S, Stockmann P, Mijatovic S, Kuhnert L, Honscha W, Hey-Hawkins E, Maksimovic-Ivanic D | 102. | AJ387 | 2023 | M21a | E | Article | PHARMACEUTICS Vol. 15 (1): #241 - (20), (DOI: 10.3390/pharmaceutics15010241) JAN 2023WOS | 7 | 4 | 10 | 7.5000 | 2.5000 | The More the Better-Investigation of Polymethoxylated N-Carboranyl Quinazolines as Novel Hybrid Breast Cancer Resistance Protein Inhibitors | Stockmann P, Kuhnert L, Leinung W, Lakoma C, Scholz B, Paskas S, Mijatovic S, Maksimovic-Ivanic D, Honscha W, Hey-Hawkins E | 103. | AJ387 | 2023 | M21a | E | Article | PHARMACEUTICS Vol. 15 (2): #682 - (19), (DOI: 10.3390/pharmaceutics15020682) FEB 2023WOS | 14 | 9 | 7 | 12.0000 | 9.0000 | Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes | Kazimir A, Schwarze B, Lönnecke P, Jelaca S, Mijatovic S, Maksimovic-Ivanic D, Hey-Hawkins E | 104. | AJ387 | 2023 | M21 | E | Article | ADVANCED THERAPEUTICS Vol. 6 (4): # - (9), (DOI: 10.1002/adtp.202200252) APR 2023WOS | 4 | 4 | 11 | 4.4444 | 2.2222 | In Vitro Cytostatic Effect on Tumor Cells by Carborane-Based Dual Cyclooxygenase-2 and 5-Lipoxygenase Inhibitors | Braun S, Paskas S, Laube M, George S, Hofmann B, Lönnecke P, Steinhilber D, Pietzsch J, Mijatovic S, Maksimovic-Ivanic D, Hey-Hawkins E | 105. | AJ387 | 2023 | M21 | E | Article | ADVANCED THERAPEUTICS Vol. 6 (8): # - (14), (DOI: 10.1002/adtp.202300117) AUG 2023WOS | 5 | 3 | 9 | 5.7143 | 2.1429 | Isonimesulide and Its Carborane Analogues as Isoform-Selective COX Inhibitors and Antitumor Agents | Useini L, Komazec T, Laube M, Lönnecke P, Schädlich J, Mijatovic S, Maksimovic-Ivanic D, Pietzsch J, Hey-Hawkins E | 106. | AJ387 | 2023 | M21 | E | Article | CHEMMEDCHEM Vol. 18 (5): # - (8), (DOI: 10.1002/cmdc.202200583) MAR 1 2023WOS | 17 | 9 | 8 | 6.6667 | 7.5000 | Carborane Analogues of Fenoprofen Exhibit Improved Antitumor Activity | Useini L, Mojic M, Laube M, Lönnecke P, Mijatovic S, Maksimovic-Ivanic D, Pietzsch J, Hey-Hawkins E | 107. | AJ387 | 2023 | M21 | E | Article | CHEMMEDCHEM Vol. 18 (14): # - (8), (DOI: 10.1002/cmdc.202300206) JUL 17 2023WOS | 4 | 3 | 11 | 4.4444 | 1.6667 | Carborane-Based Tebufelone Analogs and Their Biological Evaluation In Vitro | Braun S, Paskas S, Laube M, George S, Hofmann B, Lönnecke P, Steinhilber D, Pietzsch J, Mijatovic S, Maksimovic-Ivanic D, Hey-Hawkins E | 108. | AJ387 | 2023 | M21 | E | Article | RSC MEDICINAL CHEMISTRY Vol. 14 (12): # 2574 - 2582 (10), (DOI: 10.1039/d3md00344b) DEC 2023WOS | 7 | 4 | 7 | 8.0000 | 4.0000 | Exploring the potential of tamoxifen-based copper(ii) dichloride in breast cancer therapy | Kazimir A, Schwarze B, Lönnecke P, Jelaca S, Mijatovic S, Maksimovic-Ivanic D, Hey-Hawkins E | 109. | AJ387 | 2023 | M21 | E | Article | MICROMACHINES Vol. 14 (12): #2152 - (24), (DOI: 10.3390/mi14122152) DEC 2023WOS | 4 | 1 | 10 | 5.0000 | 0.6250 | The Second Derivative of Fullerene C60 (SD-C60) and Biomolecular Machinery of Hydrogen Bonds: Water-Based Nanomedicine | Matija L, Stankovic I, Puric M, Milicic M, Maksimovic-Ivanic D, Mijatovic S, Krajnovic T, Gordic V, Koruga D, Zhang Y | 110. | AJ387 | 2023 | M21 | E | Article | MOLECULES Vol. 28 (11): #4547 - (23), (DOI: 10.3390/molecules28114547) JUN 4 2023WOS | 7 | 4 | 11 | 4.4444 | 2.2222 | Synthesis and In Vitro Biological Evaluation of p-Carborane-Based Di-tert-butylphenol Analogs | Braun S, Jelaca S, Laube M, George S, Hofmann B, Lönnecke P, Steinhilber D, Pietzsch J, Mijatovic S, Maksimovic-Ivanic D, Hey-Hawkins E | 111. | AJ387 | 2023 | M21 | E | Article | NANOMATERIALS Vol. 13 (3): #372 - (16), (DOI: 10.3390/nano13030372) FEB 2023WOS | 8 | 4 | 9 | 5.7143 | 2.8571 | Melanoma Cell Reprogramming and Awakening of Antitumor Immunity as a Fingerprint of Hyper-Harmonized Hydroxylated Fullerene Water Complex (3HFWC) and Hyperpolarized Light Application In Vivo | Markelic M, Mojic M, Bovan D, Jelaca S, Jovic Z, Puric M, Koruga D, Mijatovic S, Maksimovic-Ivanic D | 112. | AJ387 | 2023 | M22 | E | Article | JOURNAL OF THE SERBIAN CHEMICAL SOCIETY Vol. 88 (12): # 1279 - 1291 (13), (DOI: 10.2298/JSC230818072R) 2023WOS | 0 | 0 | 7 | 5.0000 | 0.0000 | Square-pyramidal mononuclear, dinuclear and polymeric copper(II) complexes with (2-pyridinylmethyl)amino derivatives | Richter S, Lönnecke P, Bovan D, Mijatovi S, Maksimovic-Ivani D, Kaluderovi G, Hey-hawkins E | 113. | AJ387 | 2023 | M21a | E | Correction | PHARMACEUTICS Vol. 15 (6): #1769 - (2), (DOI: 10.3390/pharmaceutics15061769) JUN 2023WOS | 0 | 0 | 7 | 0 | 0.0000 | Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes (vol 15, 682, 2023) | Kazimir A, Schwarze B, Lönnecke P, Jelaca S, Mijatovic S, Maksimovic-Ivanic D, Hey-Hawkins E | 114. | AJ387 | 2024 | M21a+ | E | Article | JOURNAL OF MEDICINAL CHEMISTRY Vol. 67 (9): # 7553 - 7568 (16), (DOI: 10.1021/acs.jmedchem.4c00377) APR 19 2024WOS | 13 | 5 | 10 | 20.0000 | 5.0000 | FETPY: a Diiron(I) Thio-Carbyne Complex with Prominent Anticancer Activity In Vitro and In Vivo | Mihajlovic E, Biancalana L, Jelaca S, Chiaverini L, Dojcinovic B, Dunderovic D, Zacchini S, Mijatovic S, Maksimovic-Ivanic D, Marchetti F | 115. | AJ387 | 2024 | M21a | E | Article | DALTON TRANSACTIONS Vol. 53 (19): # 8298 - 8314 (17), (DOI: 10.1039/d4dt00182f) MAY 14 2024WOS | 16 | 7 | 13 | 5.4545 | 3.1818 | Novel triphenyltin(iv) compounds with carboxylato N-functionalized 2-quinolones as promising potential anticancer drug candidates: in vitro and in vivo evaluation | Kasalovic M, Jelaca S, Milanovic Z, Maksimovic-Ivanic D, Mijatovic S, Ladarevic J, Bozic B, Markovic Z, Dunderovic D, Rüffer T, Kretschmer R, Kaluderovic G, Pantelic N | 116. | AJ387 | 2024 | M21a | E | Article | PHARMACEUTICALS Vol. 17 (3): #286 - (22), (DOI: 10.3390/ph17030286) MAR 2024WOS | 2 | 1 | 10 | 7.5000 | 0.6250 | Dual Role of Alchemilla vulgaris L. Extract in Breast Cancer Regression: Reestablishment of Effective Immune Response | Jelaca S, Jovanovic I, Bovan D, Jovanovic M, Jurisevic M, Dunderovic D, Dajic-Stevanovic Z, Arsenijevic N, Mijatovic S, Maksimovic-Ivanic D | 117. | AJ387 | 2024 | M21a | E | Article | PHARMACEUTICALS Vol. 17 (3): #372 - (22), (DOI: 10.3390/ph17030372) MAR 2024WOS | 4 | 3 | 10 | 7.5000 | 1.8750 | Trimethyltin(IV) Bearing 3-(4-Methyl-2-oxoquinolin-1(2H)-yl)propanoate Causes Lipid Peroxidation-Mediated Autophagic Cell Death in Human Melanoma A375 Cells | Kasalovic M, Dimic D, Jelaca S, Maksimovic-Ivanic D, Mijatovic S, Zmejkovski B, Schreiner S, Rüffer T, Pantelic N, Kaluderovic G | 118. | AJ387 | 2024 | M21a | E | Article | PHARMACEUTICS Vol. 16 (11): #1437 - (20), (DOI: 10.3390/pharmaceutics16111437) NOV 2024WOS | 4 | 0 | 11 | 6.6667 | 0.0000 | A Comprehensive Evaluation of a Coumarin Derivative and Its Corresponding Palladium Complex as Potential Therapeutic Agents in the Treatment of Gynecological Cancers: Synthesis, Characterization, and Cytotoxicity | Jevtic M, Pirkovic M, Komazec T, Mojic M, Mijatovic S, Maksimovic-Ivanic D, Dimic D, Markovic Z, Simijonovic D, Milenkovic D, Avdovic E | 119. | AJ387 | 2024 | M21a | E | Article | PHARMACEUTICS Vol. 16 (12): #1529 - (24), (DOI: 10.3390/pharmaceutics16121529) DEC 2024WOS | 2 | 0 | 9 | 8.5714 | 0.0000 | Organic Moiety on Sn(IV) Does Matter for In Vitro Mode of Action: nBu3Sn(IV) Compounds with Carboxylato N-Functionalized 2-Quinolones Induce Anoikis-like Cell Death in A375 Cells | Kasalovic M, Jelaca S, Dimic D, Maksimovic-Ivanic D, Jevtic V, Mijatovic S, Rueffer T, Kaluderovic G, Pantelic N | 120. | AJ387 | 2024 | M21 | E | Article | CHEMMEDCHEM Vol. 19 (2): # - (17), (DOI: 10.1002/cmdc.202300506) JAN 15 2024WOS | 3 | 2 | 7 | 8.0000 | 2.0000 | Carboranes as Potent Phenyl Mimetics: A Comparative Study on the Reversal of ABCG2-Mediated Drug Resistance by Carboranylquinazolines and Their Organic Isosteres | Stockmann P, Kuhnert L, Krajnovic T, Mijatovic S, Maksimovic-Ivanic D, Honscha W, Hey-Hawkins E | 121. | AJ387 | 2024 | M21 | E | Article | CHEMMEDCHEM Vol. 19 (14): # - (9), (DOI: 10.1002/cmdc.202400006) JUL 15 2024WOS | 2 | 0 | 7 | 8.0000 | 0.0000 | Exploring Raloxifene-Based Metallodrugs: A Versatile Vector Combined with Platinum(II), Palladium(II) and Nickel(II) Dichlorides and Carborates against Triple-Negative Breast Cancer | Kazimir A, Götze T, Lönnecke P, Murganic B, Mijatovic S, Maksimovic-Ivanic D, Hey-Hawkins E | 122. | AJ387 | 2024 | M21 | E | Article | JOURNAL OF INORGANIC BIOCHEMISTRY Vol. 250 (): #112399 - (12), (DOI: 10.1016/j.jinorgbio.2023.112399) JAN 2024WOS | 17 | 12 | 9 | 5.7143 | 8.5714 | Novel diphenyltin(IV) complexes with carboxylato N-functionalized 2-qui- nolone ligands: Synthesis, characterization and in vitro anticancer studies | Kasalovic M, Jelaca S, Maksimovic-Ivanic D, Ladarevic J, Radovanovic L, Bozic B, Mijatovic S, Pantelic N, Kaluderovic G | 123. | AJ387 | 2024 | M21 | E | Article | SCIENTIFIC REPORTS Vol. 14 (1): #28126 - (13), (DOI: 10.1038/s41598-024-71624-8) NOV 15 2024WOS | 0 | 0 | 9 | 5.7143 | 0.0000 | The impact of 9-azaglycophymine and phenylguanidine derivatives on the proliferation of various breast cancer cell lines in vitro and in vivo | Morgan I, Rennert R, Berger R, Jelaca S, Maksimovic-Ivanic D, Dunderovic D, Mijatovic S, Kaluderovic G, Wessjohann L | 124. | AJ387 | 2024 | M21 | E | Article | SCIENTIFIC REPORTS Vol. 14 (1): #30488 - (18), (DOI: 10.1038/s41598-024-81414-x) DEC 16 2024WOS | 4 | 0 | 14 | 3.3333 | 0.0000 | Re-design and evaluation of diclofenac-based carborane-substituted prodrugs and their anti-cancer potential | Selg C, Gordic V, Krajnovic T, Buzharevski A, Laube M, Kazimir A, Lönnecke P, Wolniewicz M, Sárosi M, Schädlich J, Pietzsch J, Mijatovic S, Maksimovic-Ivanic D, Hey-Hawkins E | 125. | AJ387 | 2024 | M21 | E | Article | RSC MEDICINAL CHEMISTRY Vol. 15 (6): # - (9), (DOI: 10.1039/d4md00051j) JUN 19 2024WOS | 0 | 0 | 6 | 8.0000 | 0.0000 | Bipyraloxifene - a modified raloxifene vector against triple-negative breast cancer | Kazimir A, Götze T, Murganic B, Mijatovic S, Maksimovic-Ivanic D, Hey-Hawkins E | 126. | AJ387 | 2024 | M21 | E | Article | BIOMOLECULES Vol. 14 (4): #420 - (15), (DOI: 10.3390/biom14040420) APR 2024WOS | 5 | 1 | 8 | 6.6667 | 0.8333 | (Pentamethylcyclopentadienyl)chloridoiridium(III) Complex Bearing Bidentate Ph2PCH2CH2SPh-κP,κS Ligand | Ludwig G, Randelovic I, Dimic D, Komazec T, Maksimovic-Ivanic D, Mijatovic S, Rüffer T, Kaluderovic G | 127. | AJ387 | 2024 | M22 | E | Article | MOLECULAR BIOLOGY REPORTS Vol. 51 (1): #218 - (13), (DOI: 10.1007/s11033-023-09093-x) DEC 2024WOS | 5 | 3 | 8 | 4.1667 | 2.5000 | Anoikis and cancer cell differentiation: novel modes of shikonin derivatives anticancer action in vitro | Bovan D, Krajnovic T, Vukovic N, Vukic M, Mijatovic S, Tanic N, Arsenijevic N, Maksimovic-Ivanic D | 128. | AJ387 | 2024 | M22 | E | Article | DISEASES Vol. 12 (6): #125 - (21), (DOI: 10.3390/diseases12060125) JUN 2024WOS | 1 | 0 | 10 | 3.1250 | 0.0000 | Antimelanoma Effects of Alchemilla vulgaris: A Comprehensive In Vitro and In Vivo Study | Jelaca S, Jovanovic I, Bovan D, Pavlovic S, Gajovic N, Dunderovic D, Dajic-Stevanovic Z, Acovic A, Mijatovic S, Maksimovic-Ivanic D | 129. | AJ387 | 2025 | E | CHEMMEDCHEM Vol. 20 (1): # - (9), (DOI: 10.1002/cmdc.202400018) JAN 2 2025WOS | 5 | 0 | 9 | 0 | 0.0000 | Carborane Conjugates with Ibuprofen, Fenoprofen and Flurbiprofen: Synthesis, Characterization, COX Inhibition Potential and In Vitro Activity | Sonam S, Jelaca S, Laube M, Schädlich J, Pietzsch J, Maksimovic-Ivanic D, Mijatovic S, Kaluderovic G, Hey-Hawkins E | 130. | AJ387 | 2025 | E | CHEMMEDCHEM Vol. 20 (11): # - (14), (DOI: 10.1002/cmdc.202500084) JUN 2 2025WOS | 0 | 0 | 13 | 0 | 0.0000 | Advances in Diclofenac Derivatives: Exploring Carborane-Substituted N-Methyl and Nitrile Analogs for Anticancer Therapy | Selg C, Schuster R, Kazimir A, Lönnecke P, Wolniewicz M, Schädlich J, Laube M, Pietzsch J, Gordic V, Krajnovic T, Mijatovic S, Maksimovic-Ivanic D, Hey-Hawkins E | 131. | AJ387 | 2025 | E | BIOORGANIC CHEMISTRY Vol. 164 (): #108894 - (13), (DOI: 10.1016/j.bioorg.2025.108894) SEP 2025WOS | 0 | 0 | 8 | 0 | 0.0000 | On the tumor cell growth limiting potential of newly synthesized acridine-1,8-dione derivatives | Lazic A, Mihajlovic E, Kapavarapu R, Dordevic I, Krajnovic T, Maksimovic-Ivanic D, Mijatovic S, Trisovic N | 132. | AJ387 | 2025 | E | CHEMICO-BIOLOGICAL INTERACTIONS Vol. 418 (): #111561 - (14), (DOI: 10.1016/j.cbi.2025.111561) SEP 5 2025WOS | 0 | 0 | 9 | 0 | 0.0000 | Incorporating alkylthio groups provides potent in vitro anticancer activity to water-soluble and aqueous-stable diiron(I) bis-cyclopentadienyl complexes | Saviozzi C, Mojic M, Biancalana L, Funaioli T, Biver T, Zacchini S, Mijatovic S, Maksimovic-Ivanic D, Marchetti F | 133. | AJ387 | 2025 | E | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY Vol. 287 (): #117364 - (18), (DOI: 10.1016/j.ejmech.2025.117364) APR 5 2025WOS | 1 | 0 | 9 | 0 | 0.0000 | Anticancer activity promoted by ligand diversity in diiron thiocarbyne complexes | Mihajlovic E, Biancalana L, Mojic M, Jelaca S, Chiaverini L, Zacchini S, Mijatovic S, Maksimovic-Ivanic D, Marchetti F | 134. | AJ387 | 2025 | E | DALTON TRANSACTIONS Vol. 54 (9): # - (14), (DOI: 10.1039/d4dt03041a) FEB 25 2025WOS | 2 | 0 | 12 | 0 | 0.0000 | Platinum(ii/iv) complexes with N-substituted carboxylate ethylenediamine/propylenediamine ligands: preparation, characterization and in vitro activity | Richter S, Lönnecke P, Bovan D, Andrian N, Stoean B, Lehene M, Silaghi-Dumitrescu R, Gaina L, Mijatovic S, Maksimovic-Ivanic D, Kaluderovic G, Hey-Hawkins E | 135. | AJ387 | 2025 | E | INORGANIC CHEMISTRY FRONTIERS Vol. 12 (24): # 8650 - 8675 (26), (DOI: 10.1039/d5qi01498k) DEC 2 2025WOS | 0 | 0 | 11 | 0 | 0.0000 | A bridging thiocarbyne ligand in diiron(i) complexes enables unconventional isomerization pathways and structural diversity leading to potent cytotoxicity | Biancalana L, Mihajlovic E, Ciancaleoni G, Mojic M, Jelaca S, Zacchini S, Pampaloni G, Dojcinovic B, Maksimovic-Ivanic D, Mijatovic S, Marchetti F | 136. | AJ387 | 2025 | E | GENES Vol. 16 (10): #1170 - (14), (DOI: 10.3390/genes16101170) OCT 3 2025WOS | 0 | 0 | 10 | 0 | 0.0000 | Transcriptomic and Clinical Profiling Reveals LGALS3 as a Prognostic Oncogene in Pancreatic Cancer | Scuderi G, Mijatovic S, Maksimovic-Ivanic D, Di R, Muñoz-Valle J, Vizcaíno-Quirarte A, Leone G, Mangano K, Fagone P, Nicoletti F | 137. | AJ387 | 2025 | E | MOLECULES Vol. 30 (21): #4153 - (20), (DOI: 10.3390/molecules30214153) OCT 22 2025WOS | 0 | 0 | 12 | 0 | 0.0000 | Novel Ruthenacarborane-NSAID Conjugates | Sonam S, Mojic M, Gordic V, Laube M, Schädlich J, Pietzsch J, Nicoara A, Gaina L, Mijatovic S, Maksimovic-Ivanic D, Kaluderovic G, Hey-Hawkins E | 138. | AJ387 | 2025 | E | NANOMATERIALS Vol. 15 (17): #1320 - (27), (DOI: 10.3390/nano15171320) AUG 28 2025WOS | 0 | 0 | 9 | 0 | 0.0000 | Hybrid Platinum(IV)-Naproxen Nanostructured Drugs Reprogram Melanoma Cells and Overpower Cisplatin | Komazec T, Bovan D, Kaluderovic G, Mihajlovic E, Predarska I, Dunderovic D, Hey-Hawkins E, Mijatovic S, Maksimovic-Ivanic D |
|---|
27. 04. 2026.; 00:10:28; Trajanje procesiranja: 0.038 s
Legenda:
RB - redni broj rezultata
IBI - identifikacioni broj istraživača
Godina - godina u kojoj je rezultat publikovan (isključivo sa kompletnom paginacijom)
Kat - kategorija rezulata
Tip - tip rezultata (teorijski, simulacioni ili eksperimentalni)
Vrsta - vrsta rezultata
Referenca - referenca rezultata (bez autora i naslova rezultata) sa direktnim linkom na rezultat (ako ima DOI broj), sa linkom na zapis u eNauci ili WOS
TC - ukupan broj citata rezulata na dan 31. 1. 2026. godine
TCP - ukupan broj citata rezultata u periodu 2015-2024
BA - broj autora na rezultatu
NBB - normirani broj bodova rezultata
NTC - normirani broj citata rezultata u periodu 2015-2024
Naslov - naslov rezultata
Autori - spisak svih autora ili najviše prvih 30 autora
Primer:
Primer normiranja broja M poena i broja citata ostvarenih na jednom rezultatu: eksperimentalni rad sa 11 autora u časopisu kategorije M21a+ koji je publikovan 2020. godine, citiran je 65 puta, od čega 55 puta u periodu 2015-2024. godine.
Normirani broj M poena koje istraživač ostvaruje na rezultatu je 20/(1+0.2*(11-10))=16.6667 a normirani broj citata je 55/(1+0.2*(11-10))=45.8333.
Ukupan broj ostaverinih bodova utvrđuje se na naznačenom periodu za sabiranje normiranih M poena svakog istraživača i u periodu za određivanje ukupnog broja normiranih citata (2015-2024).